Biomarkers in spinal muscular atrophy
Spinal muscular atrophy is a hereditary disorder leading to severe neuromuscular impairment. With the introduction of disease-modifying therapies in recent years, the role of biomarkers has expanded from aiding diagnosis to monitoring treatment responses, prognostic assessment, and the development o...
Saved in:
Main Authors: | Liping Yan, Jinping Zhang, Jian Zheng, Hua Hao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2025.1636992/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcomes of genetic testing and prenatal diagnosis of spinal muscular atrophy in Jordan
by: Mohammad Shboul, et al.
Published: (2025-12-01) -
Molecular mechanism of neurodegeneration in spinal muscular atrophy
by: A. I. Vlasenko, et al.
Published: (2024-09-01) -
Spinal Muscular Atrophy 5q under the Mask of Myopathy: 10 Clinical Cases
by: Sergei A. Kurbatov
Published: (2021-12-01) -
Factors modifying the course of spinal muscular atrophy 5q
by: M. A. Akhkiamova, et al.
Published: (2024-01-01) -
Characteristics of genetic changes in the <i>SMN1</i> gene in spinal muscular atrophy 5q
by: A. V. Dil, et al.
Published: (2022-09-01)